功能状态改变了瘤亡因子-α对抑郁症治疗反应的影响
Jae-Min Kim1, Hee-Ju Kang1, Ju-Wan Kim1
1Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.
BJPsych open
|September 16, 2025
概括
较高的血清瘤坏死因子-α (sTNF-α) 水平预测抗抑郁药治疗反应较差. 功能状态缓解了这种效应,在包含时提高了预测准确性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
背景情况:
- 血清瘤坏死因子-α (sTNF-α) 与抗抑郁药治疗结果之间的联系正在争论中.
- 了解治疗反应的预测因素对于管理抑郁症疾病至关重要.
研究的目的:
- 为了研究基线sTNF-α水平对12周抗抑郁药治疗结果的影响.
- 评估功能状态是否能缓解sTNF-α与抑郁症患者治疗反应之间的关系.
主要方法:
- 基线sTNF-α和功能状态 (SOFAS) 在1086名患者中被测量.
- 治疗抗抑郁药的反应在12周后使用汉密尔顿抑郁症评分表 (缓解定义为≤7) 来评估.
- 使用后勤回归分析,调整共变量.
主要成果:
- 增加的sTNF-α水平与12周后缓解的可能性较低显著相关.
- 这种关联在具有更高功能状态 (SOFAS分数) 的患者中更为明显.
- 在功能状态较低的患者中,sTNF-α和缓解之间没有发现显著的关联.
结论:
- 基线sTNF-α水平显示为预测12周抗抑郁药治疗结果的生物标志物.
- 将功能状态整合到预测模型中可以提高预测抗抑郁药治疗反应的准确性.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Depression: Overview
794
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
794
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202


